Related Experiment Video
Updated: Jun 16, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
New 1,5-benzodiazepine compounds: activity at native GABA(A) receptors
E Gatta1, A Cupello, M Di Braccio
1Dipartimento di Fisica, Università di Genova, Via Dodecaneso 33, 16146 Italy.
Neuroscience
|January 26, 2010
Summary
New 1,5-benzodiazepine compounds were synthesized and tested for effects on GABA(A) receptors. One compound showed full agonist activity, but a sulfur substitution changed it to a probable inverse agonist, highlighting a critical binding pocket position.
Area of Science:
- Neuroscience
- Pharmacology
- Medicinal Chemistry
Background:
- GABA(A) receptors are crucial for neuronal inhibition in the central nervous system.
- Benzodiazepines modulate GABA(A) receptor activity, with 1,4- and 1,5-benzodiazepine subtypes exhibiting distinct properties.
- Understanding structure-activity relationships of novel benzodiazepines is key for developing targeted therapeutics.
Purpose of the Study:
- To synthesize and evaluate novel 1,5-benzodiazepine compounds for their biological activity.
- To investigate the effects of these compounds on different GABA(A) receptor populations (phasic and tonic inhibition).
- To compare the activity of new compounds with known benzodiazepines like flunitrazepam and clobazam.
Main Methods:
- Synthesis of various new 1,5-benzodiazepine derivatives.
- Assessment of biological activity on rat cerebellar granule cell GABA(A) receptors in culture.
- Evaluation of effects on both phasic and tonic inhibition mediated by GABA(A) receptors.
- Comparative analysis with flunitrazepam (1,4-benzodiazepine agonist) and clobazam (1,5-benzodiazepine antiepileptic).
Main Results:
- Several synthesized compounds exhibited inverse agonist profiles towards both GABA(A) receptor populations.
- One compound demonstrated full agonist activity at the GABA(A) receptor component mediating phasic inhibition.
- Substitution of an oxygen atom with sulfur in a specific morpholine ring position dramatically altered activity from full agonist to probable inverse agonist.
- This sulfur substitution indicated a critical proton-accepting site within the benzodiazepine binding pocket.
Conclusions:
- Novel 1,5-benzodiazepine compounds possess diverse modulatory effects on GABA(A) receptors.
- A specific structural modification (oxygen to sulfur substitution) significantly impacts pharmacological activity.
- The identified position is critical for ligand interaction within the GABA(A) receptor binding pocket, influencing agonist/inverse agonist profiles.
More Related Videos
Related Concept Videos
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...